{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:52:09Z","timestamp":1772185929562,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81403118"],"award-info":[{"award-number":["81403118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10822-017-0028-3","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T05:20:06Z","timestamp":1497590406000},"page":"625-641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products"],"prefix":"10.1007","volume":"31","author":[{"given":"Qi","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(98)80122-1","volume":"2","author":"LL Johnson","year":"1998","unstructured":"Johnson LL, Dyer R, Hupe DJ (1998) Matrix metalloproteinases. Curr Opin Chem Biol 2:466\u2013471","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"28_CR2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.ajpath.2012.08.044","volume":"181","author":"LA Shuman Moss","year":"2012","unstructured":"Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG (2012) Matrix metalloproteinases changing roles in tumor progression and metastasis. Am J Pathol 181(6):1895\u20131899","journal-title":"Am J Pathol"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jobcr.2015.06.015","volume":"5","author":"A Jaina","year":"2015","unstructured":"Jaina A, Bahuguna R (2015) Role of matrix metalloproteinases in dental caries, pulp and periapical inflammation: an overview. J Oral Biol Craniofac Res 5:212\u2013218","journal-title":"J Oral Biol Craniofac Res"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40279-014-0265-8","volume":"45","author":"Nascimento D Cunha da","year":"2015","unstructured":"da Cunha Nascimento D, de Cassia Marqueti Durigan R, Tibana RA, Durigan JLQ, Navalta JW, Prestes J (2015) The response of matrix metalloproteinase-9 and -2 to exercise. Sports Med 45:269\u2013278","journal-title":"Sports Med"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pathophys.2007.02.001","volume":"15","author":"Y Asano","year":"2008","unstructured":"Asano Y, Iwai S, Okazaki M, Kumai T, Munemasa Y, Oonuma S, Tadokoro M, Kobayashi S, Oguchi K (2008) Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats. Pathophysiology 15:157\u2013166","journal-title":"Pathophysiology"},{"issue":"4","key":"28_CR6","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0002-9440(10)64401-X","volume":"161","author":"V Lambert","year":"2002","unstructured":"Lambert V, Munaut C, Jost M, No\u00ebl A, Werb Z, Foidart JM, Rakic JM (2002) Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol 161(4):1247\u20131253","journal-title":"Am J Pathol"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s101200050008","volume":"1","author":"A Torii","year":"1998","unstructured":"Torii A, Kodera Y, Ito M, Shimizu Y, Hirai T, Yasui K, Morimoto T, Yamamura Y, Kato T, Hayakawa T, Fujimoto N, Kito T (1998) Matrix metalloproteinase 9 in mucosally invasive gastric cancer. Gastric Cancer 1:142\u2013145","journal-title":"Gastric Cancer"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ejcdt.2014.07.017","volume":"63","author":"AA Farhat","year":"2014","unstructured":"Farhat AA, Mohamad AS, Shareef MM, Attia GA, Eid MA, Taha RW (2014) Asthma remodeling: the pathogenic role of matrix metalloproteinase-9. Egypt J Chest Dis Tubercul 63:755\u2013759","journal-title":"Egypt J Chest Dis Tubercul"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0197-0186(03)00004-4","volume":"43","author":"S Lorenzl","year":"2003","unstructured":"Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Flint Beal M (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer\u2019s disease. Neurochem Int 43:191\u2013196","journal-title":"Neurochem Int"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/ar1454","volume":"7","author":"WU Kim","year":"2005","unstructured":"Kim WU, Min SY, Cho ML, Hong KH, Shin YJ, Park SH Cho CS (2005) Elevated matrix metalloproteinase-9 in patients with systemic. Arthritis Res Ther 7:71\u201379","journal-title":"Arthritis Res Ther"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2013.12.009","volume":"81","author":"A Kaplan","year":"2014","unstructured":"Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, Akay T, Aebischer P, Henderson CE (2014) Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 81:333\u2013348","journal-title":"Neuron"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-005-9085-3","volume":"287","author":"MR Vijayababu","year":"2006","unstructured":"Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, Arunakaran J (2006) Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287:109\u2013116","journal-title":"Mol Cell Biochem"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/scbi.2000.0365","volume":"11","author":"WG Stetler-Stevenson","year":"2001","unstructured":"Stetler-Stevenson WG, Yu AE (2001) Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 11:143\u2013152","journal-title":"Semin Cancer Biol"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1021\/jm500505f","volume":"57","author":"B Fabre","year":"2014","unstructured":"Fabre B, Ramos A, de Pascual-Teresa B (2014) Targeting matrix metalloproteinases: exploring the dynamics of the S1\u2032 pocket in the design of selective, small molecule inhibitors. J Med Chem 57:10205\u201310219","journal-title":"J Med Chem"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1005722729132","volume":"15","author":"SM Wojtowicz-Praga","year":"1997","unstructured":"Wojtowicz-Praga SM, Dickson RB, Hawkins MJ (1997) Matrix metalloproteinase inhibitors. Invest New Drug 15:61\u201375","journal-title":"Invest New Drug"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer\u2014trials and Tribulations. Science 295:2387\u20132392","journal-title":"Science"},{"key":"28_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1023047431869","volume":"22","author":"M Pavlaki","year":"2003","unstructured":"Pavlaki M, Zucker S (2003) Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer Metast Rev 22:177\u2013203","journal-title":"Cancer Metast Rev"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1568009054064615","volume":"5","author":"F Mannello","year":"2005","unstructured":"Mannello F, Tonti G, Papa S (2005) Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr Cancer Drug Target 5:285\u2013298","journal-title":"Curr Cancer Drug Target"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(03)00042-1","volume":"99","author":"L Reddy","year":"2003","unstructured":"Reddy L, Odhav B, Bhoola KD (2003) Natural products for cancer prevention: a global perspective. Pharmacol Ther 99:1\u201313","journal-title":"Pharmacol Ther"},{"key":"28_CR20","first-page":"4146","volume":"20","author":"LY Wang","year":"2012","unstructured":"Wang LY, Li X, Zhang SD, Lu WQ, Liao S, Liu XF, Shan L, Shen X, Jiang HL, Zhang WD, Huang J, Li HL (2012) Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Bioorg Med Chem 20:4146\u20134171","journal-title":"Bioorg Med Chem"},{"key":"28_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157489206775246421","volume":"1","author":"F Mannello","year":"2006","unstructured":"Mannello F (2006) Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the Horizon. Recent Pat Anti-Canc Drug Discov 1:91\u2013103","journal-title":"Recent Pat Anti-Canc Drug Discov"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1055\/s-2004-832630","volume":"70","author":"C Ende","year":"2004","unstructured":"Ende C, Gebhardt R (2004) Inhibition of MMP-2 and MMP-9 activities by selected flavonoids. Planta Med 70:1006\u20131008","journal-title":"Planta Med"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2005.05.009","volume":"362","author":"UH Jin","year":"2005","unstructured":"Jin UH, Chung TW, Kang SK, Suh SJ, Kim JK, Chung KH, Gu YH, Suzuki I, Kim CH (2005) Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta 362:57\u201364","journal-title":"Clin Chim Acta"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1016\/j.lfs.2005.02.028","volume":"77","author":"UH Jin","year":"2005","unstructured":"Jin UH, Lee JY, Kang SK, Kim JK, Park WH, Kim JG, Moon SK, Kim CH (2005) A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci 77:2760\u20132769","journal-title":"Life Sci"},{"issue":"4","key":"28_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0028-1112205","volume":"75","author":"C Wierzchacz","year":"2009","unstructured":"Wierzchacz C, Su E, Kolander J, Gebhardt R (2009) Differential inhibition of matrix metalloproteinases-2, -9, and -13 activities by selected anthraquinones. Planta Med 75(4):327\u2013329","journal-title":"Planta Med"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drudis.2007.09.007","volume":"13","author":"G Wolber","year":"2008","unstructured":"Wolber G, Seidel T, Bendix F, Langer T (2008) Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discov Today 13:23\u201329","journal-title":"Drug Discov Today"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15:444\u2013450","journal-title":"Drug Discov Today"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmgm.2013.12.008","volume":"49","author":"S Kalva","year":"2014","unstructured":"Kalva S, Azhagiya Singam ER, Rajapandian V, Saleena LM, Subramanian V (2014) Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies. J Mol Graph Model 49:25\u201337","journal-title":"J Mol Graph Model"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jphp.12133","volume":"65","author":"AK Halder","year":"2013","unstructured":"Halder AK, Saha A, Jha T (2013) Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors. J Pharm Pharmacol 65:1541\u20131554","journal-title":"J Pharm Pharmacol"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jmgm.2013.06.005","volume":"44","author":"S Kalva","year":"2013","unstructured":"Kalva S, Saranyah K, Suganya PR, Nisha M, Saleena LM (2013) Potent inhibitors precise to S1 loop of MMP-13, a crucial target for osteoarthritis. J Mo Graph Model 44:297\u2013310","journal-title":"J Mo Graph Model"},{"key":"28_CR31","unstructured":"Discovery Studio, (2010) Version 3.0 Accelrys, Inc., San Diego"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2016.01.053","volume":"11","author":"C Camodeca","year":"2016","unstructured":"Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A (2016) Discovery of a new selective inhibitor of a disintegrin and metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin\u2019s lymphoma cell models. Eur J Med Chem 11:193\u2013201","journal-title":"Eur J Med Chem"},{"key":"28_CR33","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1021\/acs.jmedchem.5b00367","volume":"58","author":"E Nuti","year":"2015","unstructured":"Nuti E, Cantelmo AR, Gallo C, Bruno A, Bassani B, Camodeca C, Tuccinardi T, Vera L, Orlandini E, Nencetti S, Stura EA, Martinelli A, Dive V, Albini A, Rossello A (2015) N-O-Isopropyl sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors: hit selection and in vivo antiangiogenic activity. J Med Chem 58:7224\u20137240","journal-title":"J Med Chem"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsb.2013.03.015","volume":"182","author":"C Antoni","year":"2013","unstructured":"Antoni C, Vera L, Devel L, Catalani MP, Czarny B, Cassar-Lajeunesse E, Nuti E, Rossello A, Dive V, Stura EA (2013) Crystallization of bi-functional ligand protein complexes. J Struct Biol 182:246\u2013254","journal-title":"J Struct Biol"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jmb.2007.05.068","volume":"371","author":"A Tochowicz","year":"2007","unstructured":"Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, Zanda M, Bode W, Goettig P (2007) Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible arg424 side-chain to selectivity. J Mol Biol 371:989\u20131006","journal-title":"J Mol Biol"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ci400348f","volume":"53","author":"X Xue","year":"2013","unstructured":"Xue X, Wei JL, Xu LL, Xi MY, Xu XL, Liu F, Guo XK, Wang L, Zhang XJ, Zhang MY, Lu MC, Sun HP, You QD (2013) Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors. J Chem Inf Model 53:2715\u20132729","journal-title":"J Chem Inf Model"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1007\/s00894-011-1328-5","volume":"18","author":"WT Tai","year":"2012","unstructured":"Tai WT, Lu T, Yuan HL, Wang FX, Liu HC, Lu S, Leng Y, Zhang WW, Jiang YL, Chen YD (2012) Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors. J Mol Model 18:3087\u20133100","journal-title":"J Mol Model"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J (2016) Binding DB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:1045\u20131063","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"28_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10822-008-9189-4","volume":"22","author":"JJ Irwin","year":"2008","unstructured":"Irwin JJ (2008) Community benchmarks for virtual screening. J Comput Aided Mol Des 22(3):193\u2013199","journal-title":"J Comput Aided Mol Des"},{"issue":"14","key":"28_CR40","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594","journal-title":"J Med Chem"},{"issue":"7","key":"28_CR41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52(7):1757\u20131768","journal-title":"J Chem Inf Model"},{"key":"28_CR42","unstructured":"AnalytiCon Discovery, GmbH, Potsdam, Germany"},{"key":"28_CR43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/07391102.2011.10507381","volume":"29","author":"HZ Xie","year":"2011","unstructured":"Xie HZ, Liu LY, Ren JX, Zhou JP, Zheng RL, Li LL, Yang SY (2011) Pharmacophore modeling and hybrid virtual screening for the discovery of novel IkappaB kinase 2 (IKK2) inhibitors. J Biomol Struct Dyn 29:165\u2013179","journal-title":"J Biomol Struct Dyn"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/ci900345h","volume":"50","author":"R Thilagavathi","year":"2015","unstructured":"Thilagavathi R, Mancera RL (2015) Ligand\u2013protein cross-docking with water molecules. J Chem Inf Model 50:415\u2013421","journal-title":"J Chem Inf Model"},{"issue":"1\u20133","key":"28_CR45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"28_CR46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/ml200031m","volume":"2","author":"HZ Zhong","year":"2011","unstructured":"Zhong HZ, Wees MA, Faure TD, Carrillo C, Arbiser J, Bowen JP (2011) The impact of ionization states of matrix metalloproteinase inhibitors on docking-based inhibitor design. ACS Med Chem Lett 2:455\u2013460","journal-title":"ACS Med Chem Lett"},{"key":"28_CR47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jmgm.2010.01.004","volume":"28","author":"M Tiwari","year":"2010","unstructured":"Tiwari M, Lee JK (2010) Molecular modeling studies of L-arabinitol 4-dehydrogenase of hypocrea jecorina: its binding interactions with substrate and cofactor. J Mol Graph Model 28:707\u2013713","journal-title":"J Mol Graph Model"},{"key":"28_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/e4e8ca0c-f6e8-4b32-aae1-b5f8e0c7ebc3","volume":"7","author":"HB Huang","year":"2012","unstructured":"Huang HB, Liu NN, Guo HP, Liao SY, Li XF, Yang CS, Liu ST, Song WB, Liu CJ, Guan LX, Li B, Xu L, Zhang CG, Wang XJ, Dou QP, Liu JB (2012) L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro. PLoS ONE 7:1\u201310","journal-title":"PLoS ONE"},{"key":"28_CR49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1139\/cjc-2014-0180","volume":"92","author":"ZG Zhou","year":"2014","unstructured":"Zhou ZG, Yao QZ, Lei D, Zhang QQ, Zhang J (2014) Investigations on the mechanisms of interactions between matrix metalloproteinase 9 and its flavonoid inhibitors using a combination of molecular docking, hybrid quantum mechanical\/molecular mechanical calculations, and molecular dynamics simulations. Can J Chem 92:821\u2013830","journal-title":"Can J Chem"},{"key":"28_CR50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/prot.340230104","volume":"23","author":"RH Stote","year":"1995","unstructured":"Stote RH, Karplus M (1995) Zinc binding in proteins and solution: a simple but accurate nonbonded representation. Proteins 23:12\u201331","journal-title":"Proteins"},{"key":"28_CR51","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/poc.3025","volume":"25","author":"J Zhang","year":"2012","unstructured":"Zhang J, Li H, Fan YR, Zhou X (2012) Mechanisms of interaction between luteolin and the catalytic zinc ion in matrix metalloproteinases: a computational study. J Phys Org Chem 25:1306\u20131314","journal-title":"J Phys Org Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-017-0028-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-017-0028-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T09:20:25Z","timestamp":1500369625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-017-0028-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s10822-017-0028-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]}}}